Zielinski R - Search Results

1

Consensus minimum data set for lung cancer multidisciplinary teams: Results of a Delphi process.

Stone E, Rankin N, Phillips J, Fong K, Currow DC, Miller A, Largey G, Zielinski R, Flynn P, Shaw T. Stone E, et al. Among authors: zielinski r. Respirology. 2018 Oct;23(10):927-934. doi: 10.1111/resp.13307. Epub 2018 Apr 11. Respirology. 2018. PMID: 29641841

2

Australian consensus guidelines for the safe handling of monoclonal antibodies for cancer treatment by healthcare personnel.

Alexander M, King J, Bajel A, Doecke C, Fox P, Lingaratnam S, Mellor JD, Nicholson L, Roos I, Saunders T, Wilkes J, Zielinski R, Byrne J, MacMillan K, Mollo A, Kirsa S, Green M. Alexander M, et al. Among authors: zielinski r. Intern Med J. 2014 Oct;44(10):1018-26. doi: 10.1111/imj.12564. Intern Med J. 2014. PMID: 25302720

3

Systematic Review of Neoadjuvant Immunotherapy for Patients With Non-Small Cell Lung Cancer.

Cao C, Guo A, Chen C, Chakos A, Bott M, Yang CJ, Zielinski R, Melfi F. Cao C, et al. Among authors: zielinski r. Semin Thorac Cardiovasc Surg. 2021 Autumn;33(3):850-857. doi: 10.1053/j.semtcvs.2020.12.012. Epub 2021 Jan 12. Semin Thorac Cardiovasc Surg. 2021. PMID: 33444765 Free PMC article.

4

Impact of COVID-19 on cancer service delivery: a follow-up international survey of oncology clinicians.

Chazan G, Franchini F, Alexander M, Banerjee S, Mileshkin L, Blinman P, Zielinski R, Karikios D, Pavlakis N, Peters S, Lordick F, Ball D, Wright G, IJzerman M, Solomon BJ. Chazan G, et al. Among authors: zielinski r. ESMO Open. 2021 Oct;6(5):100224. doi: 10.1016/j.esmoop.2021.100224. Epub 2021 Jul 9. ESMO Open. 2021. PMID: 34461484 Free PMC article.

5

Neoadjuvant immunotherapy for patients with non-small cell lung cancer-current evidence.

Cao C, Guo A, Chen C, Zielinski R, Bott M. Cao C, et al. Among authors: zielinski r. Ann Transl Med. 2020 Nov;8(22):1476. doi: 10.21037/atm-20-5026. Ann Transl Med. 2020. PMID: 33313221 Free PMC article. No abstract available.

6

Feasibility and preliminary effectiveness of virtual reality as a patient education tool for people with cancer undergoing immunotherapy: a protocol for a randomised controlled pilot study in a regional setting.

van der Kruk SR, Gunn KM, MacDougall H, Milne D, Smith K, Zielinski R. van der Kruk SR, et al. Among authors: zielinski r. BMJ Open. 2023 Jun 13;13(6):e071080. doi: 10.1136/bmjopen-2022-071080. BMJ Open. 2023. PMID: 37311632 Free PMC article.

7

Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians.

Chazan G, Franchini F, Alexander M, Banerjee S, Mileshkin L, Blinman P, Zielinski R, Karikios D, Pavlakis N, Peters S, Lordick F, Ball D, Wright G, I Jzerman M, Solomon B. Chazan G, et al. Among authors: zielinski r. ESMO Open. 2020 Dec;5(6):e001090. doi: 10.1136/esmoopen-2020-001090. ESMO Open. 2020. PMID: 33262203 Free PMC article.

8

Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian Population.

Ahmadzada T, Cooper WA, Holmes M, Mahar A, Westman H, Gill AJ, Nordman I, Yip PY, Pal A, Zielinski R, Pavlakis N, Nagrial A, Daneshvar D, Brungs D, Karikios D, Aleksova V, Burn J, Asher R, Grau GE, Hosseini-Beheshti E, Reid G, Clarke S, Kao S. Ahmadzada T, et al. Among authors: zielinski r. JTO Clin Res Rep. 2020 Jul 16;1(4):100075. doi: 10.1016/j.jtocrr.2020.100075. eCollection 2020 Nov. JTO Clin Res Rep. 2020. PMID: 34589956 Free PMC article.

9

Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population.

Walpole I, Lee B, Shapiro J, Thomson B, Lipton L, Ananda S, Usatoff V, Mclachlan SA, Knowles B, Fox A, Wong R, Cooray P, Burge M, Clarke K, Pattison S, Nikfarjam M, Tebbutt N, Harris M, Nagrial A, Zielinski R, Chee CE, Gibbs P. Walpole I, et al. Among authors: zielinski r. Asia Pac J Clin Oncol. 2023 Feb;19(1):214-225. doi: 10.1111/ajco.13807. Epub 2022 Jul 13. Asia Pac J Clin Oncol. 2023. PMID: 35831999

10

Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry.

Santucci J, Tacey M, Thomson B, Michael M, Wong R, Shapiro J, Jennens R, Clarke K, Pattison S, Burge M, Zielinski R, Nikfarjam M, Ananda S, Lipton L, Gibbs P, Lee B. Santucci J, et al. Among authors: zielinski r. Eur J Cancer. 2022 Oct;174:102-112. doi: 10.1016/j.ejca.2022.06.042. Epub 2022 Aug 18. Eur J Cancer. 2022. PMID: 35988408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters